<p>Given are parameters for disease onset (A-C), and survival (D) for the SOD-1 (G93A) (n = 17) and SOD-1 (G93A)<sup>PS</sup> mice (n = 8). (A) Onset of weight decrease was defined as a drop of 5% of the mouse maximal weight. (B) First manifestation of symptoms that are linked to gait impairment in terms of limbs coordination and overall stance, and (C) time to first manifestation of paresis. (D) End point of the disease, defined as the inability of the mouse to right itself within 30 seconds.</p
<p>Clinical signs from individual mice were recorded and assigned a value according to the following...
<p>Kaplan-Meier survival curves of (A) male and female SOD1 DJ-1 KO mice and SOD1 mice.(B) The avera...
The effective treatment or cure of motoneuron disease will require understanding the disease process...
<p>(A) Motor signs (hind limb tremors) were measured with the clinical scoring system (see methods)....
<p>A, Weight of female mice. B, Weight of male mice. Disease onset was calculated retrospectively as...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
<p>Grip strength measurements of C57 SOD1G93A (A) and 129Sv SOD1G93A (B) mice analysed in vivo for T...
<p>(A) The SOD-1 (G93A)<sup>PS</sup> mice (n = 8) have a delayed onset of weight decrease when compa...
<p>Accelerated deterioration of gait was observed in SOD1 DJ-1 KO mice as compared to SOD1 mice. The...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
As a model for amyotrophic lateral sclerosis (ALS), transgenic hSOD1(G93A) mice constitute the stand...
<p>(A) Control and MB-treated (10 mg intraperitoneal injection per kg body weight per day) SOD1<sup>...
<p>The motor function and deterioration was evaluated by Rotarod (A, female mice; B, male mice). The...
<p>The difference in neurological score was significant between the control group (SD) and KD group ...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>Clinical signs from individual mice were recorded and assigned a value according to the following...
<p>Kaplan-Meier survival curves of (A) male and female SOD1 DJ-1 KO mice and SOD1 mice.(B) The avera...
The effective treatment or cure of motoneuron disease will require understanding the disease process...
<p>(A) Motor signs (hind limb tremors) were measured with the clinical scoring system (see methods)....
<p>A, Weight of female mice. B, Weight of male mice. Disease onset was calculated retrospectively as...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
<p>Grip strength measurements of C57 SOD1G93A (A) and 129Sv SOD1G93A (B) mice analysed in vivo for T...
<p>(A) The SOD-1 (G93A)<sup>PS</sup> mice (n = 8) have a delayed onset of weight decrease when compa...
<p>Accelerated deterioration of gait was observed in SOD1 DJ-1 KO mice as compared to SOD1 mice. The...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
As a model for amyotrophic lateral sclerosis (ALS), transgenic hSOD1(G93A) mice constitute the stand...
<p>(A) Control and MB-treated (10 mg intraperitoneal injection per kg body weight per day) SOD1<sup>...
<p>The motor function and deterioration was evaluated by Rotarod (A, female mice; B, male mice). The...
<p>The difference in neurological score was significant between the control group (SD) and KD group ...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>Clinical signs from individual mice were recorded and assigned a value according to the following...
<p>Kaplan-Meier survival curves of (A) male and female SOD1 DJ-1 KO mice and SOD1 mice.(B) The avera...
The effective treatment or cure of motoneuron disease will require understanding the disease process...